62 related articles for article (PubMed ID: 9326165)
1. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
Kreiss K; Mroz MM; Zhen B; Wiedemann H; Barna B
Occup Environ Med; 1997 Aug; 54(8):605-12. PubMed ID: 9326165
[TBL] [Abstract][Full Text] [Related]
2. Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.
McKee AS; Atif SM; Falta MT; Fontenot AP
J Immunol; 2022 Apr; 208(8):1835-1843. PubMed ID: 35418504
[TBL] [Abstract][Full Text] [Related]
3. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
[TBL] [Abstract][Full Text] [Related]
4. Genomic biomarkers in chronic beryllium disease and sarcoidosis.
Lin NW; Maier LA; Mroz MM; Jacobson S; MacPhail K; Liu S; Lei Z; Barkes BQ; Fingerlin TE; Hamzeh N; Mayer AS; Restrepo CI; Chhabra D; Yang IV; Li L
Respir Med; 2021 Oct; 187():106390. PubMed ID: 34399367
[TBL] [Abstract][Full Text] [Related]
5. TLR9 and IL-1R1 Promote Mobilization of Pulmonary Dendritic Cells during Beryllium Sensitization.
Wade MF; Collins MK; Richards D; Mack DG; Martin AK; Dinarello CA; Fontenot AP; McKee AS
J Immunol; 2018 Oct; 201(8):2232-2243. PubMed ID: 30185516
[TBL] [Abstract][Full Text] [Related]
6. Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.
Kreiss K; Fechter-Leggett ED; McCanlies EC; Schuler CR; Weston A
J Occup Environ Med; 2016 Sep; 58(9):855-60. PubMed ID: 27414009
[TBL] [Abstract][Full Text] [Related]
7. Simulation, design, and testing of a high power collimator for the RDS-112 cyclotron.
Peeples JL; Stokely MH; Poorman MC; Bida GT; Wieland BW
Appl Radiat Isot; 2015 Mar; 97():87-92. PubMed ID: 25562677
[TBL] [Abstract][Full Text] [Related]
8. Migration of Beryllium via Multiple Exposure Pathways among Work Processes in Four Different Facilities.
Armstrong JL; Day GA; Park JY; Stefaniak AB; Stanton ML; Deubner DC; Kent MS; Schuler CR; Virji MA
J Occup Environ Hyg; 2014; 11(12):781-92. PubMed ID: 25357184
[TBL] [Abstract][Full Text] [Related]
9. A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.
Fireman E; Lerman Y; Stark M; Pardo A; Schwarz Y; Van Dyke MV; Elliot J; Barkes B; Newman L; Maier L
J Occup Environ Hyg; 2014; 11(12):809-18. PubMed ID: 24856577
[TBL] [Abstract][Full Text] [Related]
10. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
[TBL] [Abstract][Full Text] [Related]
11. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.
Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Cragle DL; Tankersley WG; Wells SM; Newman LS; Maier LA
Occup Environ Med; 2011 Nov; 68(11):842-8. PubMed ID: 21460389
[TBL] [Abstract][Full Text] [Related]
12. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.
Mroz MM; Maier LA; Strand M; Silviera L; Newman LS
Am J Ind Med; 2009 Oct; 52(10):762-73. PubMed ID: 19681064
[TBL] [Abstract][Full Text] [Related]
13. A reconsideration of acute Beryllium disease.
Cummings KJ; Stefaniak AB; Virji MA; Kreiss K
Environ Health Perspect; 2009 Aug; 117(8):1250-6. PubMed ID: 19672405
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.
Thomas CA; Bailey RL; Kent MS; Deubner DC; Kreiss K; Schuler CR
Public Health Rep; 2009; 124 Suppl 1(Suppl 1):112-24. PubMed ID: 19618813
[TBL] [Abstract][Full Text] [Related]
15. Progression from beryllium exposure to chronic beryllium disease: an analytic model.
Harber P; Bansal S; Balmes J
Environ Health Perspect; 2009 Jun; 117(6):970-4. PubMed ID: 19590692
[TBL] [Abstract][Full Text] [Related]
16. Genetic determinants of sensitivity to beryllium in mice.
Tarantino-Hutchison LM; Sorrentino C; Nadas A; Zhu Y; Rubin EM; Tinkle SS; Weston A; Gordon T
J Immunotoxicol; 2009 Jun; 6(2):130-5. PubMed ID: 19589099
[TBL] [Abstract][Full Text] [Related]
17. The bioinorganic chemistry and associated immunology of chronic beryllium disease.
Scott BL; McCleskey TM; Chaudhary A; Hong-Geller E; Gnanakaran S
Chem Commun (Camb); 2008 Jul; (25):2837-47. PubMed ID: 18566702
[TBL] [Abstract][Full Text] [Related]
18. Beryllium's public relations problem: protecting workers when there is no safe exposure level.
Michaels D; Monforton C
Public Health Rep; 2008; 123(1):79-88. PubMed ID: 18348484
[No Abstract] [Full Text] [Related]
19. Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program.
Donovan EP; Kolanz ME; Galbraith DA; Chapman PS; Paustenbach DJ
Int Arch Occup Environ Health; 2007 Nov; 81(2):165-78. PubMed ID: 17483959
[TBL] [Abstract][Full Text] [Related]
20. Beryllium exposure: dermal and immunological considerations.
Day GA; Stefaniak AB; Weston A; Tinkle SS
Int Arch Occup Environ Health; 2006 Feb; 79(2):161-4. PubMed ID: 16231190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
